Bryan K Nam, MD
Internal Medicine · Fullerton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 10 years
- Loma Linda University School of Medicine, 2016
Offices
3 locations · Providence Medical Foundation · 1,461 clinicians in this group
Hospitals listed: 051659 · Providence St. Joseph Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Nam’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A150404 · Current
Licensed to practise in California · since 2017 · expires 2027-02-28 · Loma Linda University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence St. Joseph HospitalOrange, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 2 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.244, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.452, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence St. Joseph Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.244 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.452 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.72 (0 to 1.63) · 1,757 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.9 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 153.26 (103.87 to 202.66) · 120 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 53 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 355 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.7 · 525 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.9 · 351 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,583 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.44) · 6,824 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,239 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.93 (2.16 to 5.71) · 2,444 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.66 (1.16 to 4.15) · 1,091 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.95 (1.66 to 4.23) · 2,251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.53 (7.56 to 17.49) · 1,162 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (3.51 to 9.73) · 1,142 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.54 (0.11 to 2.98) · 779 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.15) · 5,803 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.8 · 96 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.182 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.042 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.84 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 332 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 757 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.4 · 142 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.9 · 405 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.8 · 539 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 953 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.4) · 201 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8.1 to 14.1) · 201 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 95 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.4 to 16.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.6) · 352 cases | No different | Jan 2024 – Dec 2024 |
What patients said (450 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$58,253
Medicare paid this office $58,253 for 261 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 153 | $20,016 | $63 |
| Hospital discharge day management, more than 30 minutes | 138 | $13,423 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 92 | $13,090 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $6,397 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,070 | $97 |
Who their Medicare patients are
261 Original Medicare patients in 2024. Average age 78 · Under 65 12% · 85 and older 35% · Women 57% · Also on Medicaid 40% · Health risk score 3.06. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Heart failure 54% · Chronic kidney disease 50% · Coronary heart disease 49% · Diabetes 48% · Atrial fibrillation 38% · Depression 37% · COPD 29% · Dementia 28% · Stroke 26% · Cancer 21%.
The office billed $205,771, Medicare allowed $74,691 and paid $58,253; for 675 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 261 | 675 | 78 | 3.06 | $205,771 | $58,253 |
| 2023 | 230 | 618 | 78 | 3.11 | $169,123 | $53,832 |
| 2022 | 215 | 494 | 78 | 2.62 | $135,105 | $42,516 |
| 2021 | 256 | 680 | 75 | 3.20 | $127,975 | $60,058 |
| 2020 | 258 | 852 | 76 | 3.44 | $158,839 | $79,000 |
| 2019 | 99 | 244 | 79 | 2.96 | $48,234 | $23,356 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $18,096 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $11,410 | $139 |
| Hospital discharge day management, more than 30 minutes | 107 | $10,241 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $7,156 | $97 |
| Return visit (30+ min) | 18 | $1,768 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,394 | $93 |
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $12,112 | $57 |
| Initial hospital observation care per day, typically 70 minutes | 48 | $6,759 | $141 |
| Hospital discharge day management, more than 30 minutes | 57 | $5,296 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,271 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $4,397 | $83 |
| Hospital observation care on day of discharge | 24 | $1,460 | $61 |
| Follow-up observation care per day, typically 25 minutes | 12 | $664 | $55 |
2021: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 108 | $14,501 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $12,281 | $86 |
| Initial hospital observation care per day, typically 70 minutes | 59 | $8,988 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,321 | $170 |
| Hospital discharge day management, more than 30 minutes | 85 | $8,032 | $91 |
| Hospital discharge day management, 30 minutes or less | 30 | $1,869 | $60 |
| Hospital observation care on day of discharge | 29 | $1,807 | $62 |
2020: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 164 | $42,795 | $90 |
| Initial hospital observation care per day, typically 70 minutes | 59 | $9,120 | $155 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,152 | $170 |
| Hospital discharge day management, more than 30 minutes | 62 | $5,896 | $91 |
| Hospital discharge day management, 30 minutes or less | 75 | $4,695 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $3,433 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,498 | $88 |
| Follow-up observation care per day, typically 35 minutes | 14 | $1,354 | $90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $773 | $37 |
2019: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $8,372 | $88 |
| Initial hospital observation care per day, typically 70 minutes | 24 | $3,934 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,086 | $171 |
| Hospital discharge day management, 30 minutes or less | 36 | $2,251 | $63 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,202 | $92 |
| Follow-up observation care per day, typically 35 minutes | 14 | $1,512 | $89 |
Medicaid work
$1,085 in 2023
Medicaid paid $1,085 for 24 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 24 | $1,085 |
| 2023 | 24 | 1 | 12 | $1,085 |
| 2021 | 36 | 1 | 12 | $1,484 |
| 2020 | 70 | 1 | 16 | $2,834 |
See the largest Medicaid services in earlier years
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 36 | $1,484 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 70 | $2,834 |
Drugs they prescribed that Part D paid
$28,548
Pharmacies billed $28,548 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (25 of 479) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
406 generic and fewer than 11 brand-name prescriptions · $28,548 in drug cost · 95 antibiotic prescriptions to 76 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $6,406 | $582 |
| Cefpodoxime Proxetil | 15 | $467 | $31 |
| Ondansetron Odt | 25 | $259 | $10 |
| Famotidine | 17 | $113 | $7 |
| Amoxicillin-Clavulanate Potass | 14 | $95 | $7 |
See all 13 drugs
| Eliquis | 11 | $6,406 | $582 |
| Cefpodoxime Proxetil | 15 | $467 | $31 |
| Ondansetron Odt | 25 | $259 | $10 |
| Famotidine | 17 | $113 | $7 |
| Amoxicillin-Clavulanate Potass | 14 | $95 | $7 |
| Doxycycline Hyclate | 15 | $91 | $6 |
| Pantoprazole | 13 | $76 | $6 |
| Furosemide | 19 | $69 | $4 |
| Hydralazine | 13 | $52 | $4 |
| Levofloxacin | 12 | $50 | $4 |
| Losartan | 11 | $45 | $4 |
| Atorvastatin | 16 | $40 | $3 |
| Prednisone | 18 | $35 | $2 |
Year by year
| 2024 | 479 | 233 | 5% (25) | None | $28,548 |
| 2023 | 514 | 218 | 5% (25) | None | $34,985 |
| 2022 | 332 | 159 | None | None | $19,532 |
| 2021 | 483 | 194 | 5% (22) | None | $41,901 |
| 2020 | 339 | 149 | 7% (23) | None | $16,954 |
| 2019 | 135 | 61 | None | 8% | $4,588 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Eliquis | 12 | $7,638 | $637 |
| Cefpodoxime Proxetil | 11 | $359 | $33 |
| Clopidogrel | 14 | $160 | $11 |
| Atorvastatin | 22 | $153 | $7 |
| Hydralazine | 15 | $121 | $8 |
| Pantoprazole | 17 | $107 | $6 |
| Ondansetron Odt | 12 | $93 | $8 |
| Amoxicillin-Clavulanate Potass | 13 | $79 | $6 |
| Cefdinir | 11 | $72 | $7 |
| Hydrocodone-Acetaminophen | 11 | $66 | $6 |
| Furosemide | 28 | $66 | $2 |
| Levofloxacin | 16 | $51 | $3 |
| Amlodipine Besylate | 11 | $48 | $4 |
| Azithromycin | 12 | $39 | $3 |
2022: 7 drugs
| Cefdinir | 20 | $268 | $13 |
| Ondansetron Odt | 12 | $184 | $15 |
| Atorvastatin | 15 | $129 | $9 |
| Pantoprazole | 15 | $126 | $8 |
| Amoxicillin-Clavulanate Potass | 13 | $126 | $10 |
| Prednisone | 12 | $55 | $5 |
| Furosemide | 17 | $30 | $2 |
2021: 11 drugs
| Eliquis | 34 | $17,480 | $514 |
| Albuterol Sulfate Hfa | 11 | $461 | $42 |
| Ondansetron Odt | 14 | $185 | $13 |
| Amoxicillin-Clavulanate Potass | 19 | $184 | $10 |
| Pantoprazole | 14 | $115 | $8 |
| Atorvastatin | 16 | $115 | $7 |
| Furosemide | 23 | $89 | $4 |
| Losartan | 11 | $75 | $7 |
| Prednisone | 19 | $63 | $3 |
| Hydrocodone-Acetaminophen | 12 | $51 | $4 |
| Metoprolol | 14 | $43 | $3 |
2020: 8 drugs
| Eliquis | 12 | $5,782 | $482 |
| Amoxicillin-Clavulanate Potass | 20 | $187 | $9 |
| Pantoprazole | 16 | $181 | $11 |
| Atorvastatin | 16 | $146 | $9 |
| Gabapentin | 12 | $94 | $8 |
| Hydrocodone-Acetaminophen | 15 | $76 | $5 |
| Furosemide | 15 | $50 | $3 |
| Amlodipine Besylate | 13 | $29 | $2 |
Money from drug and device companies
$65 in 2025
| 2025 | 1 | 2 | None | $65 |
| 2024 | 4 | 5 | None | $135 |
| 2023 | 1 | 2 | None | $48 |
| 2022 | 1 | 1 | None | $31 |
| 2020 | 1 | 2 | None | $135 |
| 2019 | 3 | 3 | None | $138 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Eliquis | $65 | 2 payments
|
See all 2 published payments
| Pfizer | Meals · 2025-03-19 | Eliquis | $32 |
| Pfizer | Meals · 2025-01-09 | Eliquis | $33 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $135
| Pfizer | Eliquis | $54 | 2 payments
|
| Scpharmaceuticals | Furoscix | $30 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $27 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
2023: $48
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $48 | 2 payments
|
2022: $31
| Pfizer | Eliquis | $31 | 1 payment
|
2020: $135
| Novo Nordisk | Ozempic | $135 | 2 payments
|
2019: $138
| E.R. Squibb & Sons L.L.C. | None | $101 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $23 | 1 payment
|
| GlaxoSmithKline | Nucala | $14 | 1 payment
|
Professional record
- NPI
- 1578925467
- Licence
- CA A150404California A150404: Current · expires 2027-02-28
- Trained
- Loma Linda University School of Medicine, 2016 · 10 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 2501 E Chapman Ave, Orange, CA, 92869
- NPI first listed
- 2016-03-22
- NPI last updated
- 2019-09-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128